Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Change in Accured Expenses (2023 - 2025)

Upstream Bio (UPB) has 3 years of Change in Accured Expenses data on record, last reported at -$481000.0 in Q3 2025.

  • For Q3 2025, Change in Accured Expenses fell 285.71% year-over-year to -$481000.0; the TTM value through Sep 2025 reached $2.9 million, up 644.44%, while the annual FY2024 figure was $1.5 million, 258.29% up from the prior year.
  • Change in Accured Expenses reached -$481000.0 in Q3 2025 per UPB's latest filing, down from $3.5 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $3.5 million in Q2 2025 and bottomed at -$1.9 million in Q1 2025.
  • Average Change in Accured Expenses over 3 years is $418000.0, with a median of $320500.0 recorded in 2024.
  • The widest YoY moves for Change in Accured Expenses: up 822.77% in 2025, down 285.71% in 2025.
  • A 3-year view of Change in Accured Expenses shows it stood at $639000.0 in 2023, then surged by 174.65% to $1.8 million in 2024, then crashed by 127.41% to -$481000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were -$481000.0 in Q3 2025, $3.5 million in Q2 2025, and -$1.9 million in Q1 2025.